ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Obituaries: Karen Johnson of NCI; Merrill Egorin of UPCI

September 17, 2010

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

Guest Opinion: Long Island Study’s Value Now Rests In Its Repository

November 2, 2002

Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds

January 27, 2006

ACS Asks Reagan To Back Stronger Cigarette Warning

April 2, 1982